MARKET NEWS

Arctoris & Syntekabio Form Drug Discovery Research Partnership
Orasis Raises $30 Million to Advance Clinical Development Program
Imanis Life Sciences Presents a First-in-Class Neutralizing Antibody Test for COVID-19
Fortress Biotech Announces Initiation of Phase 3 Studies 
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine
Catalent to be Added to S&P 500 Index

  FEATURED EDITORIAL

  COMPANY PROFILE

Alcami is a world-class, fully-integrated contract development and manufacturing organization (CDMO) headquartered in North Carolina, with executive offices in Durham and Wilmington. Alcami helps biologics and pharmaceutical companies of all sizes navigate the complex road of delivering breakthrough therapies to patients faster, from concept to commercialization. Alcami connects its global clients with customizable and innovative solutions for API development and manufacturing, solid state chemistry, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing (oral solid dose and parenteral), packaging, and stability services. Click here for more.

  EXCLUSIVE ONLINE CONTENT

CombiGene & Cobra Biologics Sign Agreement to Secure GMP Production of Plasmids for Production of Gene Therapy

CombiGene & Cobra Biologics Sign Agreement to Secure GMP Production of Plasmids for Production of Gene Therapy

Cobra Biologics and CombiGene AB (publ) (CombiGene) recently announced they have signed agreements covering Good Manufacturing Practice (GMP) production of two essential….

Gain Therapeutics Announces Research Collaboration With Sumitomo Dainippon Pharma

Gain Therapeutics Announces Research Collaboration With Sumitomo Dainippon Pharma

Gain Therapeutics, Inc. recently announced it has entered into a strategic research collaboration agreement with Sumitomo Dainippon Pharma Co., Ltd. for the research and development of….

Novus Announces Acquisition of Anelixis

Novus Announces Acquisition of Anelixis

Novus Therapeutics, Inc. recently announced it has completed the acquisition of Anelixis Therapeutics, Inc., a privately held clinical-stage biotechnology company developing a next-generation….

Vectura Partners With Monash University to Support Development of Inhaled Oxytocin to Prevent Postpartum Haemorrhage

Vectura Partners With Monash University to Support Development of Inhaled Oxytocin to Prevent Postpartum Haemorrhage

Vectura Group plc recently announced it has signed an agreement with Monash University’s Institute of Pharmaceutical Sciences (MIPS) to develop inhaled oxytocin delivered via a….

Thermo Fisher Scientific Partners With AstraZeneca & the University of Nebraska Medical Center

Thermo Fisher Scientific Partners With AstraZeneca & the University of Nebraska Medical Center

Thermo Fisher Scientific recently announced new collaborations of the Thermo Fisher Precision Medicine Science Center (PMSC) with AstraZeneca and the University of Nebraska Medical Center as part of its ongoing development of….

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

September 30 – Gene Therapy
October 7 – API Synthesis